The induction of caspase-3 cleavage and upon cetuximab/cisplatin cotreatment was previously reported in the HCT116 and SW480 colon cancer cell lines, where both molecules seem to synergize [44]. This evidence concerns the gene CASP3 and colonic neoplasm.